GLA and Fabry disease: The confirmation of Fabry disease is achieved through the implementation of genetic and biochemical tests, which are designed to identify the potential existence of a specific genetic alteration and to assess the activity of the enzyme alpha-galactosidase A. The determination of the enzyme’s substrates, Gb3 and Lyso-Gb3, also contributes significantly to the diagnosis [8].